ArticleScientific reports2026
Clinically interpretable extracellular vesicle gene model for Non-Invasive liver cancer diagnosis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Hepatocellular carcinoma (HCC) is a major cause of cancer-related mortality worldwide, underscoring the need for improved non-invasive diagnostic strategies. In this study, we developed an interpretable machine learning model using extracellular vesicle (EV)-derived RNA signatures from the exoRBase 3.0 database. Six machine learning algorithms were evaluated, among which a Deep Neural Network achieved numerically higher discriminative performance under the experimental setup used in this study (AUC = 0.8877) on an internal hold-out test set. A panel of ten diagnostic mRNAs (MTRNR2L8, HBB, PF4, FTL, MTRNR2L12, TMSB4X, PPBP, OST4, ACTB, and S100A9) were identified, with MTRNR2L8 showing the strongest contribution to model predictions. SHapley Additive exPlanations and Kolmogorov–Arnold Networks were applied to enhance interpretability and to characterize nonlinear relationships between EV-derived gene expression features and classification outcomes. An online prediction interface was implemented as a demonstration tool to illustrate potential applicability. Overall, this study presents an exploratory, proof-of-concept framework for EV-based HCC classification. Further validation in independent and prospective cohorts will be required before clinical application can be considered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.